Doximity, Inc.
HealthcareNYSE:DOCS · New York Stock Exchange
+$0.02 today
Vol 1.98M · Avg 3.86M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $219.2M |
| Short-term Investments | $529.4M |
| Receivables | $144.8M |
| Other Current | $50.9M |
| Total Current Assets | $944.3M |
| PP&E (Net) | $25.2M |
| Goodwill | $85.0M |
| Intangible Assets | $35.3M |
| Tax Assets | $32.0M |
| Other Non-current | $1.9M |
| Total Non-current Assets | $179.4M |
| Total Assets | $1.1B |
Analysis
Selected assets total $1.1B for Latest. The largest visible component is Short-term Investments at $529.4M, about 47.1% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $219.2M +4.6% | $209.6M +116.6% | $96.8M -38.8% | $158.0M +40.1% | $112.8M | $1.2B | $1.0B | $841.8M |
| Short-term Investments | $529.4M -25.0% | $706.0M +6.0% | $666.1M -2.5% | $683.0M -0.3% | $685.3M | -$1.7B | -$1.6B | $445.6M |
| Net Receivables | $144.8M +12.8% | $128.4M +26.7% | $101.3M -5.3% | $107.0M +32.0% | $81.1M | $668.2M | $533.8M | $399.4M |
| Inventory | $0 | $0 | $0 | $0 | $0 | $652.8M | $641.6M | $328.0M |
| Other Current Assets | $50.9M +14.1% | $44.6M -8.4% | $48.7M +77.7% | $27.4M +397.2% | $5.5M | -$1.7B | $1.5B | $966.4M |
| Total Current Assets | $944.3M -13.3% | $1.1B +19.2% | $912.9M -6.4% | $975.5M +7.9% | $904.1M | $3.6B | $12.5B | $10.5B |
| Property, Plant & Equipment (Net) | $25.2M +11.9% | $22.5M -8.6% | $24.6M -1.8% | $25.1M +162.1% | $9.6M | $575.8M | $1.2B | $1.5B |
| Goodwill | $85.0M +25.1% | $67.9M +0.0% | $67.9M +0.0% | $67.9M +259.2% | $18.9M | $1.4B | $925.8M | $466.6M |
| Intangible Assets | $35.3M +53.1% | $23.1M -15.5% | $27.3M -14.2% | $31.8M +302.5% | $7.9M | $1.4B | $568.8M | $860.0M |
| Long-term Investments | $0 | $0 | $0 | $0 | $0 | $1.2B | $524.0M | -$1.5B |
| Tax Assets | $32.0M -46.7% | $60.0M +33.2% | $45.1M +29.1% | $34.9M -28.1% | $48.6M | $364.4M | $1.5B | $1.4B |
| Other Non-current Assets | $1.9M -9.4% | $2.1M +45.5% | $1.5M -11.9% | $1.7M -26.9% | $2.3M | $1.4B | $1.4B | $1.0B |
| Total Non-current Assets | $179.4M +2.1% | $175.7M +5.6% | $166.4M +3.1% | $161.4M +85.1% | $87.2M | $4.7B | -$15.3B | $14.8B |
| Total Assets | $1.1B -11.1% | $1.3B +17.1% | $1.1B -5.1% | $1.1B +14.7% | $991.4M | $14.6B | $13.3B | $11.9B |
| Account Payables | $4.0M +195.6% | $1.4M -39.8% | $2.3M +77.1% | $1.3M +174.7% | $463.0K | $1.2B | $1.3B | -$1.5B |
| Short-term Debt | $2.1M | $0 | $0 | $0 | $0 | $1.2B | -$1.6B | -$1.6B |
| Tax Payables | $0 -100.0% | $1.4M -90.3% | $14.0M +832.0% | $1.5M +91.6% | $785.0K | $708.8M | $574.4M | -$1.5B |
| Deferred Revenue | $106.0M -7.2% | $114.3M +15.3% | $99.1M -5.8% | $105.2M +23.9% | $84.9M | $340.6M | -$1.6B | $374.2M |
| Other Current Liabilities | $42.8M +254.9% | $12.1M -18.4% | $14.8M +23.9% | $11.9M +144.1% | $4.9M | $650.0M | $1.1B | $1.5B |
| Total Current Liabilities | $155.0M -0.8% | $156.3M +6.1% | $147.3M +5.6% | $139.5M +25.4% | $111.3M | $12.8B | $6.0B | $10.1B |
| Long-term Debt | $0 | $0 | $0 | $0 | $0 | $483.4M | $1.3B | $438.6M |
| Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $1.2B | $746.6M | $612.2M |
| Deferred Revenue (Non-current) | $400.0K +42.9% | $280.0K +32.7% | $211.0K +6.6% | $198.0K +153.8% | $78.0K | $1.0B | -$1.6B | $715.8M |
| Other Non-current Liabilities | $9.4M -37.2% | $15.0M -17.4% | $18.1M +5.5% | $17.2M +1697.3% | $956.0K | $1.2B | $489.0M | $1.1B |
| Total Non-current Liabilities | $17.9M -29.7% | $25.4M -17.2% | $30.7M -1.7% | $31.3M +2011.1% | $1.5M | $11.3B | $3.9B | $7.5B |
| Total Liabilities | $172.8M -4.9% | $181.7M +2.1% | $178.0M +4.2% | $170.8M +51.4% | $112.8M | $8.8B | $14.7B | $3.7B |
| Common Stock | $183.0K -3.2% | $189.0K +1.1% | $187.0K -3.6% | $194.0K +1.0% | $192.0K | $785.8M | $651.4M | $517.0M |
| Retained Earnings | -$51.1M -127.3% | $186.9M +133.6% | $80.0M -63.3% | $217.9M +14.0% | $191.1M | $1.0B | -$1.6B | $519.8M |
| Accumulated OCI | $28.0K -97.9% | $1.3M +149.7% | -$2.7M +81.1% | -$14.1M +7.9% | -$15.3M | -$1.6B | $393.8M | $550.6M |
| Other Stockholders Equity | $0 | $0 | $0 | $0 | $0 | $486.2M | $351.8M | -$1.6B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $853.0M | $1.4B | $337.8M |
| Total Equity | $950.8M -12.2% | $1.1B +20.1% | $901.4M -6.7% | $966.1M +10.0% | $878.6M | $10.4B | $9.1B | $7.7B |
| Total Debt | $10.2M -17.8% | $12.4M -14.8% | $14.5M -7.0% | $15.6M +1335.9% | $1.1M | $735.4M | $724.2M | $410.6M |
| Net Debt | -$209.0M -6.0% | -$197.2M -139.8% | -$82.2M +42.2% | -$142.4M -27.5% | -$111.7M | -$1.7B | $389.6M | $501.6M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Exact Sciences Corporation
EXAS
$20.03B
Viatris Inc.
NASDAQ:VTRS
$19.19B
Guardant Health, Inc.
NASDAQ:GH
$17.45B
Solventum Corporation
NYSE:SOLV
$13.66B
The Cooper Companies, Inc.
NASDAQ:COO
$13.24B
ICON Public Limited Company
NASDAQ:ICLR
$11.19B
Revvity, Inc.
NYSE:RVTY
$11.12B
Encompass Health Corporation
NYSE:EHC
$10.07B
Tempus AI, Inc.
NASDAQ:TEM
$8.35B
HealthEquity, Inc.
NASDAQ:HQY
$7.39B
SEC Filings
Recent regulatory filings
No filings found.
How much cash does DOCS have?
Doximity, Inc. (DOCS) reported $219.18M in cash and equivalents in fiscal 2026.
How much debt does DOCS carry?
Doximity, Inc. (DOCS) reported $10.19M of total debt, with net debt of -$208,993,000.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.